Media Coverage
The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
-
WGN
–
It’s Not Unusual for Your Child to Take More Than One Anxiety Medication
Dr. Sterling Elliott, clinical pharmacist at Northwestern Medicine and assistant professor of orthopedics at Feinberg School of Medicine, joins Lisa Dent to discuss taking supplements in conjunction with medication, taking more than one anxiety medication, and if GLP-1’s are reshaping insurance costs for other people.
Later, Dr. Elliott answers listeners’ medical questions.
-
The Associated Press
–
Tanning Is Getting Hot Again. Here’s What it Really Does to Your Skin
Dr. Pedram Gerami and his team at Northwestern University’s medical school sought to find out what was happening at a cellular level with tanning bed users. They had nearly three times the risk of developing melanoma as those who did not use tanning beds.
Gerami took skin samples from tanning bed users and compared them with samples from nonusers. His team examined the DNA sequences of melanocytes, skin cells that can turn into moles, melanoma or other cancers.
-
The New York Times
–
The New Science of Inflammation
Next year, researchers at Northwestern plan to begin piloting inflammation monitors akin to those used by diabetics to track their glucose levels. These devices will measure, in real time, four or five proteins that are involved in inflammation.
Shana Kelley, a professor at Northwestern University and the head of bioengineering at the research institute Biohub, whose lab developed the inflammation-monitoring devices, gave me examples of the sorts of questions their extensive use could help answer.
-
Chicago Sun-Times
–
New Research Aims to Break the ‘Silent Epidemic’ of Long COVID
Women with Long COVID experience more intense neurological symptoms like brain fog, dizziness and numbness than men, with more severe impacts on quality of life.
That’s according to new research out of Northwestern University, with Dr. Igor Koralnik, chief of neuro-infectious disease and global neurology, Northwestern’s Feinberg School of Medicine.
-
The New York Times
–
What to Do if Your Estrogen Patch Is Out of Stock
Depending on the type of estrogen patch you use, you may be able to cobble together your dose by using the patches pharmacies have on hand, said Dr. Lauren Streicher, a clinical professor of obstetrics and gynecology at Northwestern University Feinberg School of Medicine.
If only a higher dose is available, ask your provider whether it is safe for you to cut your patch in half or quarters.
-
People
–
Questions to Ask Your Doctor After a Metastatic Breast Cancer Diagnosis
It’s hard to be prepared to react to the news of a cancer diagnosis, but this list of questions will help you get your bearings to move forward with treatment
“All women by the age of 25 should actually be getting risk assessed to see if they should be screened before the age of 40, because over 75% of our breast cancer patients don’t have a family history,” says Sonya Bhole, MD, director and physician lead of ambulatory breast radiology at Northwestern Medicine Evanston.
-
The New York Times
–
Should We Make Daylight Saving Time Permanent?
The Sunshine Protection Act, passed by the House this month, promises an easy fix to an unpopular ritual: The bill would halt the twice-yearly changing of the clocks and make daylight saving time permanent.
“The worst choice of all three options is permanent D.S.T.,” said Dr. Phyllis C. Zee, director of the Center for Circadian and Sleep Medicine at Northwestern University Feinberg School of Medicine.
-
WGN
–
Dr. Santina Wheat With the Latest on the Cyclospora Outbreak
Dr. Santina Wheat, Program Director, McGaw Northwestern Family Medicine Residency at Northwestern Medicine Delnor Hospital, joins Wendy Snyder for this week’s health update.
They discuss the latest on the cyclospora outbreak, warning signs for heart failure, and the screening tests you should not blow off.
-
Fox Chicago
–
The Hidden Cost of GLP-1s: Popularity Surge Raises Long-Term Affordability Questions
As the use of GLP-1s has surged across the United States, the average total payments per user have also climbed sharply, a new study reveals.
Senior author Xiaoning Huang, an assistant professor of medicine in Northwestern University’s Feinberg School of Medicine, also said the financial impact of expanding GLP-1 use extends well beyond patients taking the drugs.
-
WGN
–
Northwestern Researchers Test Nanoparticle Treatment to Save Donor Livers
Roughly 18 to 20 percent of patients on the waiting list will get too sick, or they’ll die before they receive a transplant. Local researchers hope to solve that problem with a little help from nanoparticles.
“Compared to 10 to 15 years ago, most of the donors were in better shape. Now it’s not uncommon that we open, and we see the donor liver, and it’s fatty,” said Dr. Daniel Borja-Cacho, a transplant surgeon at Northwestern Medicine.
